Serial #87869060
DEAD

Serial Number

87869060

Owner

H. Lundbeck A/S

Attorney

Maren C. Perry

Filing Date

Apr 9, 2018

Add to watchlist:

No watchlists yet
View on USPTO

Serial #87869060 Trademark

Serial Number: 87869060 • Registration: 5831126

Serial #87869060 is a trademark filed by H. Lundbeck A/S on April 9, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

April 9, 2018

Registration Date

August 13, 2019

Published for Opposition

May 28, 2019

Cancellation Date

February 27, 2026

Goods & Services

Paper, cardboard, paper labels, printed publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, science, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine, medicine, pharmaceuticals, disorders, diseases, treatment and prevention

Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, disease awareness, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine, medicine, pharmaceuticals, disorders, diseases, clinical or medical treatment and prevention; software for medical and pharmaceutical information, education and sales activities, namely, software featuring audio and video information for pharmaceutical representatives on the subject of pharmaceuticals for use in the treatment of medical conditions; software for analyzing medical and pharmaceutical information and featuring information on disease symptoms for use in promoting disease awareness; software, namely, application software for mobile devices for analyzing medical and pharmaceutical information; apparatus and instruments for medical research and scientific research purposes, namely, mass spectrometers for analyzing medical and pharmaceutical information in the field of research and development, science, clinical studies, medical clinical tests and trials, pharmaceuticals, disorders and diseases; electronic downloadable publications, namely, magazines, journals, teaching and educational materials in the field of pharmaceutical research and development, science, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine related to clinical or medical treatment and prevention

Educational services, namely, conducting seminars in the field of pharmaceuticals and disease awareness; providing of training in the field of pharmaceuticals and disease awareness; arranging and conducting seminars, conferences, symposiums, training workshops and courses in the field of pharmaceuticals and disease awareness; educational training services in the fields of pharmaceutical research and development, medical clinical studies, pharmaceutical tests and trials and diagnostic medicine related to the treatment and prevention of diseases and disorders; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, namely, on-line training programs in the field of pharmaceuticals; providing on-line, non-downloadable publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, science, medical clinical studies in the field of pharmaceutical tests and trials, diagnostic medicine, pharmaceuticals, disorders, disease awareness, treatment and prevention related to the assessment of cognitive functions; providing educational assessment services in the field of cognitive functions through on-line non-downloadable screening tools

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Pharmaceutical research and development; scientific and technological services, namely, scientific testing and research related to medical disorders, medical diseases and medical prevention; scientific and technological services, namely, scientific testing and research related to the central nervous system and central nervous system related disorders, pharmaceuticals and disease awareness; medical and clinical research, namely, pharmaceutical clinical research and conducting clinical trials for others in the field of pharmaceuticals; diagnostic research and tests in the field of pharmaceutical research

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 27, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 13, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 22, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 22, 2024 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Mar 22, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 25, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 9, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 9, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 9, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2018 CRFA
ASSIGNED TO LIE
Dec 10, 2018 ALIE
ASSIGNED TO LIE
Dec 10, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 26, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 26, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 19, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 18, 2018 NWOS
NEW APPLICATION ENTERED
Apr 12, 2018 NWAP